Yellow Card

VAERS And Yellow Card Covid ‘Vaccine’ Deaths vs. Deaths From All Other Vaccines

Here is the data, in graph form.

VAERS Deaths From All Vaccines 2000- June 2021

The cumulative total deaths for 20 years prior to 2021 for all vaccines in VAERS is less than the total for just 6 months from the Covid ‘vaccines’ in 2021: 3192 vs. 4826. It’s now nearly 6000 deaths reported in VAERS.

UK Yellow Card Reported Fatalities All Other Vaccines 2011-20 vs. Covid Vaccines to June 2021

Thanks to Joel Smalley for submitting a FOI request to get this data.

Some people might be tempted to argue that the number of people ‘vaccinated’ against Covid is much greater than the number injected yearly with all other vaccines, so this is an unfair comparison. But that’s not true. In the winter season 2018/19, roughly 14 million people received the ‘flu vaccine in the UK. This is just ‘flu. How many millions received vaccines to protect against other diseases? Roughly 30 million people in the UK had received two jabs against Covid in June 2021, so the numbers vaccinated against Covid vs. all other vaccines are going to be comparable – in the multiple millions. This means that the reported death rate from the Covid ‘vaccines’ is MANY times higher than that from all other vaccines, in the US and in the UK. An unprecedented fatality rate in fact, yet still our government is pushing us to get jabbed, using extreme coercive measures combined with threats and propaganda which would not be out of place in 1930s Germany. Our government rushed these jabs through without due caution and now they are pushing like crazy for the entire populace – including children – to get jabbed. Why? Not for public health reasons that’s for sure. Here’s what Robert Malone has to say:

‘In a conventional vaccine you can precisely calculate how much protein goes into your shoulder because it’s fixed and predictable, but in the case of these genetic vaccines you can’t,’ he warned.  

‘You can’t calculate how long it produces this protein and how much protein it makes and exactly what cells in your body the protein goes into. Conventional vaccines go around your cell, but for these gene therapy-based vaccines the target is your cell.’ 

When I asked whether he thought the UK (which was the first country in the world to approve the Pfizer vaccine on December 2, 2020) rushed through their approval of it, Dr Malone quickly responded: ‘I wouldn’t say maybe, I would say they did. You can’t take a process that normally takes a decade and push it down into nine months and not cut corners.’  

Children are at very low risk of hospitalisation and death from Covid-19, Dr Malone confirmed. In their age group, the risks overwhelmingly outweigh the benefits from the vaccine.  

The risks are the cardiotoxicity events (pericarditis and myocarditis) being recorded in the adverse event databases coming out of Israel, Norway and the Netherlands, to name but a few.  

Given that the MHRA and FDA have approved the Pfizer vaccine for 12 to 15-year-olds and have been actively encouraging the use of it across multiple age groups, Dr Malone likened this application to the situation where ‘if you give a three-year-old a hammer, everything becomes a nail’. 

Update 12th July 2021

Joel has updated the VAERS data. It now looks like this:

“It is now apparent that these products in the blood stream are toxic to humans. An immediate halt to the vaccination programme is required”

These are the words of Dr Tess Lawrie (MBBCh, PhD), Director, Evidence-based Medicine Consultancy Ltd and EbMC Squared CiC, in a letter to Dr June Raine, Chief Executive of the MHRA, the same MHRA which has recently authorised the use of the Pfizer ‘vaccine’ in children aged 12-15. It is almost inconceivable that they would do this, given the number and seriousness of the adverse reactions to the ‘vaccines’ being recorded on their own ‘early warning’ database, especially when children of that age are at statistically zero risk of serious Covid disease. But we live in strange times, so strange in fact, so deeply disturbing that our government is threatening not to end lockdown restrictions completely on June 21st because they haven’t coerced enough younger people to get injected with the blood toxin they are calling a ‘vaccine’.

Here are a few relevant passages from that letter:

The Covid-19 vaccines were rolled out in the UK on the 8th of December 2020. As of the 6th May 2021 nearly 39 million people have received their first dose of the Covid-19 vaccine, and 24 million both doses. Sufficient data have now accumulated to get a good overview of adverse drug reactions (ADRs). I would, therefore, like to draw your attention to the high number of covid-19 vaccine-attributed deaths and ADRs that have been reported via the Yellow Card system between the 4th January 2021 and the 26th May 2021. In total, 1,253 deaths and 888,196 ADRs (256,224 individual reports) were reported during this period.

To facilitate a better clinical understanding of the nature of the adverse events occurring, primarily to inform doctors at the frontline, we have searched the Yellow Card reports using pathology-specific key words to group the data according to the following five broad, clinically relevant categories:

A. Bleeding, Clotting and Ischaemic ADRs

B. Immune System ADRs

C. ‘Pain’ ADRs

D. Neurological ADRs

E. ADRs involving loss of Sight, Hearing, Speech or Smell

F. Pregnancy ADRs

A. Bleeding, Clotting and Ischaemic Adverse Drug Reactions

We used the following SEARCH TERMS to identify bleeding, clotting and ischaemic ADRs: bleed, haemo*, thrombo*, emboli*, coag*, death, ischaem*, infarct*, angina, stroke, cerebrovascular, CVA.

We included the term ‘death’ in this search group, as this term accounted for many reported fatalities (438) without specific details. Given the large number of fatalities without a specific cause of death, we considered that ADRs reported in this way, in particular as ‘sudden death’, would be most likely to occur from haemorrhagic, thrombo-embolic or ischaemic events. Given the seriousness of this ADR, we considered it justifiable to do this pending a Freedom of Information (FOI) request to clarify the cause of death in these 438 people.

Using these search terms, 13,766 bleeding, clotting and ischaemic ADRs were identified – 856 of which were fatal. Government reports have highlighted the occurrence of cerebral venous sinus thrombosis, apparently accounting for 24 fatalities and 226 ADRs up to the 26th May 2021.However, our analysis indicates that thromboembolic ADRs have been reported in almost every vein and artery, including large vessels like the aorta, and in every organ including other parts of the brain, lungs, heart, spleen, kidneys, ovaries and liver, with life-threatening and life-changing consequences. The most common Yellow Card categories affected by these sorts of ADRs were the nervous system (152 fatalities, mainly from brain bleeds and clots), respiratory (with 103 fatalities, mainly from pulmonary thromboembolism) and cardiac categories (81 fatalities).

So, you see, it’s not just “extremely rare” cerebral venous sinus thromboses which are the problem here. Blood clots are forming in blood vessels throughout the body and in virtually every organ. This suggests that the vaccine and/or its spike protein product is getting into the vascular system and being distributed widely. This was not supposed to happen! To get an idea of just how massive a problem this may be, Dr Reiner Fuellmich, the German lawyer currently pursuing Covid human rights violations class action lawsuits, cites a German clinical study which measured D-dimer levels in volunteers before and after ‘vaccination’. Regardless of any adverse reactions, D-dimer levels were elevated post vaccination in almost half of volunteers, proving that clot formation was taking place. If that sample is representative of the vaccinated population as a whole, then it is truly shocking. Remember, each time you are jabbed, these toxins circulate around the blood system and the psychopaths in charge are proposing 3rd and even 4th booster jabs this winter.

Thrombo-embolic events aren’t the only problem:

B. Immune System Adverse Drug Reactions (Infection, Inflammation,Autoimmune, Allergic)

We used the following SEARCH TERMS to identify immune system ADRs: INFECTION (category), IMMUNE DISORDERS (category), -itis; immun, multiple sclerosis, lupus, myasthenia, pernicious, diabetes, Addison, Crohn’s, Coeliac, Graves, alopecia, amyloidosis, antiphospholipid, angioedema, Behcet’s, pemphigoid, psoriasis, aplasia, sarcoidosis, scleroderma, thrombocytopenia, vitiligo, Miller Fisher, Guillain-Barre; allerg*, urticaria, rash, eczema, asthma.

To the 26th May, a total of 54,870 ADRs and 171 fatalities fell into this category, which comprised the second most common cause of post-vaccination fatalities after ‘Bleeding, Clotting and Ischaemic ADRs’. However, only 4 associated fatalities were reported under the Yellow card ‘IMMUNE DISORDERS’ category, with the majority (141 fatalities associated with 19,474 ADRs) reported under the ‘INFECTIONS’ category. Among 1,187 people for whom post-vaccination COVID infection was reported, there were 72 fatalities (6% of reported COVID infection ADRs).

Many ‘INFECTION’ category ADRs indicated the occurrence of re-activation of latent viruses, including Herpes Zoster or shingles (1,827 ADRs), Herpes Simplex (943 ADRs, 1 fatal), and Rabies (1 fatal ADR) infections. This is strongly suggestive of vaccine-induced immune-compromise.Bell’s palsy, also associated with latent virus reactivation, is reported in the Neurological ADRs section of this report (D). Also suggestive of vaccine-induced immunocompromise was the high number of immune-mediated conditions reported, including Guillain-Barré Syndrome (280 ADRs, 6 deaths), Crohn’s and non-infective colitis (231 ADRs, 2 deaths) and Multiple Sclerosis (113 ADRs).

Allergic responses to the vaccines comprised 25,270 reported ADRs, with 4 fatalities occurring among 1,001 people experiencing anaphylactic reactions. 

Additionally, we have the following classes of adverse reactions which also give cause for concern:

C. ‘Pain’ Adverse Drug Reactions

D. Neurological Adverse Drug Reactions

E. Adverse Drug Reactions involving loss of sight, hearing, speech or smell

F. Pregnancy Adverse Drug Reactions

As if all that wasn’t bad enough, we also have the unforeseen potential long term adverse reactions. We know for sure now that the drug companies have screwed up by not anticipating very serious immediate adverse reactions, so it’s more than plausible that they have failed to anticipate long term serious adverse reactions too.

According to the recent paper by Seneff and Nigh (1), potential acute and long-term pathologies include:

• Pathogenic priming, multisystem inflammatory disease and autoimmunity

• Allergic reactions and anaphylaxis

• Antibody dependent enhancement

• Activation of latent viral infections

• Neurodegeneration and prion diseases

• Emergence of novel variants of SARSCoV2

• Integration of the spike protein gene into the human DNA

The author calls for an immediate halt to the vaccine rollout:

The nature and variety of ADRs reported to the Yellow Card System are consistent with the potential pathologies described in this paper and supported by other recent scientific papers on vaccine-induced harms, which are mediated through the vaccine spike protein product (2,3). It is now apparent that these products in the blood stream are toxic to humans. An immediate halt to the vaccination programme is required whilst a full and independent safety analysis is undertaken to investigate the full extent of the harms, which the UK Yellow Card data suggest include thromboembolism, multisystem inflammatory disease, immune suppression,autoimmunity and anaphylaxis, as well as Antibody Dependent Enhancement (ADE).

This is perhaps the most damning sentence in the entire letter:

The MHRA now has more than enough evidence on the Yellow Card system to declare the COVID-19 vaccines unsafe for use in humans.

Why? Well, aside from the obvious, it comes within a week of when, far from withdrawing the emergency use authorisation for these ‘vaccines’ generally, the MHRA has in fact extended their use to children who were not even included in the original trials, on the basis of a ridiculously underpowered recent clinical trial in the States. Seriously WTAF is going on?

UPDATE: Watch this video. Just watch it – before YouTube delete it. I cannot stress how important it is to view this video. It is your duty as a human being.

https://newtube.app/user/PhilStone/p01lQ7L?__cf_chl_jschl_tk__=fbe3476ad2f7ce0a4bd0fce10834b9dea6a7046c-1623771117-0-AXO4hUMwVvnapjfo0ZClBWSlb09cDq0HjI2z0CYhPGXc_W5Ov7ZsAVQhfY6WRFCxM13NS5jYamTIistagoUHUr2VlI6jRUXYq9-tcUoks9znltBw1y68hWk71hNDkyHKc0MRVnPh6Hq-yLOUrtyv7-4PUvBWjsmHaIkjOQTFi6gQd09nTmTSECI9tYHL3VlkRfGDqScii0gdnl3SEkCLlWtgh3BYspbmlSi-bFSPW5AGi3wdOweOXGiWdhMG_YMais7wnNcJVKI1ibagsyPRBImBH8KG8e4I0AaGGH5BI0VAEZFl45cIaaIZpk69bqQbxIYb3L5M6rSls1IvdivQ1Kdl3Y844Rifw0IRTAKepDJT4mrwae6Rl3Cxg5kE87xU0oX81nEDaLvnXc4uoeFTvNWeRy-QFKOXnULg3u2mftjfNd6W1FEMnlBBcsrwfRqFdZlgFvCjHK860ns96_aBUg-V07sArS1xiVXfDwS_lWsU

Here is the entire video:

https://odysee.com/@BretWeinstein:f/how-to-save-the-world,-in-three-easy:0?r=FuWwFotRbicqY9GHyWBqDdTNNHpaTgC9

Banned Paper – ‘COVID Vaccines: Necessity, Efficacy and Safety’

Seeing as how censorship is now rife on social media and academic platforms, it is incumbent upon us humble sceptical bloggers to reproduce material authored by respected critics of the official narrative, which is being censored. So here it is, originally published by medium.com, who then banned it. Here is the link to the archived version. Here is the link to the version republished by UK Column.

COVID Vaccines: Necessity, Efficacy and Safety

Doctors for Covid Ethics

Abstract: COVID-19 vaccine manufacturers have been exempted from legal liability for vaccine-induced harm. It is therefore in the interests of all those authorising, enforcing and administering COVID-19 vaccinations to understand the evidence regarding the risks and benefits of these vaccines, since liability for harm will fall on them.

In short, the available evidence and science indicate that COVID-19 vaccines are unnecessary, ineffective and unsafe.

  • Necessity: immunocompetent individuals are protected against SARS-CoV-2 by cellular immunity. Vaccinating low-risk groups is therefore unnecessary. For immunocompromised individuals who do fall ill with COVID-19 there is a range of medical treatments that have been proven safe and effective. Vaccinating the vulnerable is therefore equally unnecessary. Both immunocompetent and vulnerable groups are better protected against variants of SARS-CoV-2 by naturally acquired immunity and by medication than by vaccination.1 
  • Efficacy: Covid-19 vaccines lack a viable mechanism of action against SARS-CoV-2 infection of the airways. Induction of antibodies cannot prevent infection by an agent such as SARS-CoV-2 that invades through the respiratory tract. Moreover, none of the vaccine trials have provided any evidence that vaccination prevents transmission of the infection by vaccinated individuals; urging vaccination to “protect others” therefore has no basis in fact.
  • Safety: The vaccines are dangerous to both healthy individuals and those with pre-existing chronic disease, for reasons such as the following: risk of lethal and non-lethal disruptions of blood clotting including bleeding disorders, thrombosis in the brain, stroke and heart attack; autoimmune and allergic reactions; antibody-dependent enhancement of disease; and vaccine impurities due to rushed manufacturing and unregulated production standards.

The risk-benefit calculus is therefore clear: the experimental vaccines are needless, ineffective and dangerous. Actors authorising, coercing or administering experimental COVID-19 vaccination are exposing populations and patients to serious, unnecessary, and unjustified medical risks.

1. The vaccines are unnecessary

  1. Multiple lines of research indicate that immunocompetent people display “robust” and lasting cellular (T cell) immunity to SARS-CoV viruses [1], including SARS-CoV-2 and its variants [2]. T cell protection stems not only from exposure to SARS-CoV-2 itself, but from cross-reactive immunity following previous exposure to common cold coronaviruses [1,310]. Such immunity was detectable after infections up to 17 years prior [1,3]. Therefore, immunocompetent people do not need vaccination against SARS-Cov-2.
  2. Natural T-Cell immunity provides stronger and more comprehensive protection against all SARS-CoV-2 strains than vaccines, because naturally primed immunity recognises multiple virus epitopes and costimulatory signals, not merely a single (spike) protein. Thus, immunocompetent people are better protected against SARS-CoV-2 and any variants that may arise by their own immunity than by the current crop of vaccines.
  3. The vaccines have been touted as a means to prevent asymptomatic infection [11], and by extension “asymptomatic transmission.” However, “asymptomatic transmission” is an artefact of invalid and unreliable PCR test procedures and interpretations, leading to high false-positive rates [1215]. Evidence indicates that PCR-positive, asymptomatic people are healthy false-positives, not carriers. A comprehensive study of 9,899,828 people in China found that asymptomatic individuals testing positive for COVID-19 never infected others [16]. In contrast, the papers cited by the Centre for Disease Control [17,18] to justify claims of asymptomatic transmission are based on hypothetical models, not empirical studies; they present assumptions and estimates rather than evidence. Preventing asymptomatic infection is not a viable rationale for promoting vaccination of the general population.
  4. In most countries, most people will now have immunity to SARS-CoV-2 [19]. Depending on their degree of previously acquired cross-immunity, they will have had no symptoms, mild and uncharacteristic symptoms, or more severe symptoms, possibly including anosmia (loss of sense of smell) or other somewhat characteristic signs of the COVID-19 disease. Regardless of disease severity, they will now have sufficient immunity to be protected from severe disease in the event of renewed exposure. This majority of the population will not benefit at all from being vaccinated.
  5. Population survival of COVID-19 exceeds 99.8% globally [2022]. In countries that have been intensely infected over several months, less than 0.2% of the population have died and had their deaths classified as ‘with covid19’. It is typically a mild to moderately severe illness. Therefore, the overwhelming majority of people are not at risk from COVID-19 and do not require vaccination for their own protection.
  6. In those susceptible to severe infection, Covid-19 is a treatable illness. A convergence of evidence indicates that early treatment with existing drugs reduces hospitalisation and mortality by ~85% and 75%, respectively [2327]. These drugs include many tried and true antiinflammatory, antiviral, and anticoagulant medications, as well as monoclonal antibodies, zinc, and vitamins C and D. Industry and government decisions to sideline such proven treatments through selective research support [24], regulatory bias, and even outright sanctions against doctors daring to use such treatments on their own initiative have been out of step with existing laws, standard medical practice, and research; the legal requirement to consider real world evidence has fallen by the wayside [28]. The systematic denial and denigration of these effective therapies has underpinned the spurious justification for the emergency use authorisation of the vaccines, which requires that “no standard acceptable treatment is available” [29]. Plainly stated, vaccines are not necessary to prevent severe disease.

2. The vaccines lack efficacy

  1. At a mechanistic level, the concept of immunity to COVID-19 via antibody induction, as per COVID-19 vaccination, is medical nonsense. Airborne viruses such as SARS-CoV-2 enter the body via the airways and lungs, where antibody concentrations are too low to prevent infection. Vaccine-induced antibodies primarily circulate in the bloodstream, while concentrations on the mucous membranes of lungs and airways is low. Given that COVID-19 primarily spreads and causes disease by infecting these mucous membranes, vaccines miss the immunological mark. The documents submitted by the vaccine manufacturers to the various regulatory bodies contain no evidence that vaccination prevents airway infection, which would be crucial for breaking the chain of transmission. Thus, vaccines are immunologically inappropriate for COVID-19.
  2. Medium to long-term vaccine efficacy is unknown. Phase 3, medium term, 24-month trials will not be complete until 2023: There is no medium-term or long term longitudinal data regarding vaccine efficacy.
  3. Short term data has not established prevention of severe disease. The European Medicines Agency has noted of the Comirnaty (Pfizer mRNA) vaccine that severe COVID-19 cases “were rare in the study, and statistically certain conclusion cannot be drawn” from it [30]. Similarly, the Pfizer document submitted to the FDA [31] concludes that efficacy against mortality could not be demonstrated. Thus, the vaccines have not been shown to prevent death or severe disease even in the short term.
  4. The correlates of protection against COVID-19 are unknown. Researchers have not yet established how to measure protection against Covid-19. As a result, efficacy studies are stabbing around in the dark. After completion of Phase 1 and 2 studies, for instance, a paper in the journal Vaccine noted that “without understanding the correlates of protection, it is impossible to currently address questions regarding vaccine-associated protection, risk of COVID-19 reinfection, herd immunity, and the possibility of elimination of SARS-CoV-2 from the human population” [32]. Thus, Vaccine efficacy cannot be evaluated because we have not yet established how to measure it.

3. The vaccines are dangerous

  1. Just as smoking could be and was predicted to cause lung cancer based on first principles, all gene-based vaccines can be expected to cause blood clotting and bleeding disorders [33], based on their molecular mechanisms of action. Consistent with this, diseases of this kind have been observed across age groups, leading to temporary vaccine suspensions around the world: The vaccines are not safe.
  2. Contrary to claims that blood disorders post-vaccination are “rare”, many common vaccine side effects (headaches, nausea, vomiting and haematoma-like “rashes” over the body) may indicate thrombosis and other severe abnormalities. Moreover, vaccine-induced diffuse micro-thromboses in the lungs can mimic pneumonia and may be misdiagnosed as COVID-19. Clotting events currently receiving media attention are likely just the “tip of a huge iceberg” [34]: The vaccines are not safe.
  3. Due to immunological priming, risks of clotting, bleeding and other adverse events can be expected to increase with each re-vaccination and each intervening coronavirus exposure. Over time, whether months or years [35], this renders both vaccination and coronaviruses dangerous to young and healthy age groups, for whom without vaccination COVID-19 poses no substantive risk.

Since vaccine roll-out, COVID-19 incidence has risen in numerous areas with high vaccination rates [3638]. Furthermore, multiple series of COVID-19 fatalities have occurred shortly after the onset vaccinations in senior homes [39,40]. These cases may have been due not only to antibody-dependent enhancement but also to a general immunosuppressive effect of the vaccines, which is suggested by the increased occurrence of Herpes zoster in certain patients [41]. Immunosuppression may have caused a previously asymptomatic infection to become clinically manifest. Regardless of the exact mechanism responsible for these reported deaths, we must expect that the vaccines will increase rather than decrease lethality of COVID-19—the vaccines are not safe.

  1. The vaccines are experimental by definition. They will remain in Phase 3 trials until 2023. Recipients are human subjects entitled to free informed consent under Nuremberg and other protections, including the Parliamentary Assembly of the Council of Europe’s resolution 2361 [42] and the FDA’s terms of emergency use authorisation [29]. With respect to safety data from Phase 1 and 2 trials, in spite of initially large sample sizes, the journal Vaccine reports that “the vaccination strategy chosen for further development may have only been given to as few as 12 participants” [32]. With such extremely small sample sizes, the journal notes that “larger Phase 3 studies conducted over longer periods of time will be necessary” to establish safety. The risks that remain to be evaluated in Phase 3 trials into 2023, with entire populations as subjects, include not only thrombosis and bleeding abnormalities, but other autoimmune responses, allergic reactions, unknown tropisms (tissue destinations) of lipid nanoparticles [35], antibody-dependent enhancement [4346] and the impact of rushed, questionably executed, poorly regulated [47] and reportedly inconsistent manufacturing methods, conferring risks of potentially harmful impurities such as uncontrolled DNA residues [48]. The vaccines are not safe, either for recipients or for those who use them or authorise their use.
  2. Initial experience might suggest that the adenovirus-derived vaccines (AstraZeneca/Johnson & Johnson) cause graver adverse effects than the mRNA (Pfizer/Moderna) vaccines. However, upon repeated injection, the former will soon induce antibodies against the proteins of the adenovirus vector. These antibodies will then neutralize most of the vaccine virus particles and cause their disposal before they can infect any cells, thereby limiting the intensity of tissue damage.

In contrast, in the mRNA vaccines, there is no protein antigen for the antibodies to recognize. Thus, regardless of the existing degree of immunity, the vaccine mRNA is going to reach its target—the body cells. These will then express the spike protein and subsequently suffer the full onslaught of the immune system. With the mRNA vaccines, the risk of severe adverse events is virtually guaranteed to increase with every successive injection. In the long term, they are therefore even more dangerous than the vector vaccines. Their apparent preferment over the latter is concerning in the highest degree; these vaccines are not safe.

4. Ethics and legal points to consider

  1. Conflicts of interest abound in the scientific literature and within organisations that recommend and promote vaccines, while demonising alternate strategies (reliance on natural immunity and early treatment). Authorities, doctors and medical personnel need to protect themselves by evaluating the sources of their information for conflicts of interest extremely closely.
  2. Authorities, doctors and medical personnel need to be similarly careful not to ignore the credible and independent literature on vaccine necessity, safety and efficacy, given the foreseeable mass deaths and harms that must be expected unless the vaccination campaign is stopped.
  3. Vaccine manufacturers have exempted themselves from legal liability for adverse events for a reason. When vaccine deaths and harms occur, liability will fall to those responsible for the vaccines’ authorisation, administration and/or coercion via vaccine passports, none of which can be justified on a sober, evidence-based risk-benefit analysis.
  4. All political, regulatory and medical actors involved in COVID-19 vaccination should familiarise themselves with the Nuremberg code and other legal provisions in order to protect themselves.

References

  1. Le Bert, N. et al. (2020) SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature 584:457-462
  2. Tarke, A. et al. (2021) Negligible impact of SARS-CoV-2 variants on CD4+ and CD8+ T cell reactivity in COVID-19 exposed donors and vaccinees. bioRxiv -:x-x
  3. Anonymous, (2020) Scientists uncover SARS-CoV-2-specific T cell immunity in recovered COVID-19 and SARS patients.
  4. Beasley, D. (2020) Scientists focus on how immune system T cells fight coronavirus in absence of antibodies.
  5. Bozkus, C.C. (2020) SARS-CoV-2-specific T cells without antibodies. Nat. Rev. Immunol. 20:463
  6. Grifoni, A. et al. (2020) Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell 181:1489-1501.e15
  7. Mateus, J. et al. (2020) Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. Science 370:89-94
  8. McCurry-Schmidt, M. (2020) Exposure to common cold coronaviruses can teach the immune system to recognize SARS-CoV-2.
  9. Palmer, S. et al. (2021) COVID-19 hospitalization rates rise exponentially with age, inversely proportional to thymic T-cell production. J. R. Soc. Interface 18:20200982
  10. Sekine, T. et al. (2020) Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19. Cell 183:158-168.e14
  11. Drake, J. (2021) Now We Know: Covid-19 Vaccines Prevent Asymptomatic Infection, Too.
  12. Bossuyt, P.M. (2020) Testing COVID-19 tests faces methodological challenges. Journal of clinical epidemiology 126:172-176
  13. Jefferson, T. et al. (2020) Viral cultures for COVID-19 infectivity assessment. Systematic review. Clin. Infect. Dis. ciaa1764:x-x
  14. Borger, P. et al. (2020) External peer review of the RTPCR test to detect SARS-CoV-2 reveals 10 major scientific flaws at the molecular and methodological level: consequences for false positive results.
  15. Mandavilli, A. (2020) Your Coronavirus Test Is Positive. Maybe It Shouldn’t Be.
  16. Cao, S. et al. (2020) Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China. Nat. Commun. 11:5917
  17. Moghadas, S.M. et al. (2020) The implications of silent transmission for the control of COVID-19 outbreaks. Proc. Natl. Acad. Sci. U. S. A. 117:17513-17515
  18. Johansson, M.A. et al. (2021) SARS-CoV-2 Transmission From People Without COVID-19 Symptoms. JAMA network open 4:e2035057
  19. Yeadon, M. (2020) What SAGE got wrong.
  20. Ioannidis, J.P.A. (2020) Global perspective of COVID‐19 epidemiology for a full‐cycle pandemic. Eur. J. Clin. Invest. 50:x-x
  21. Ioannidis, J.P.A. (2021) Reconciling estimates of global spread and infection fatality rates of COVID‐19: An overview of systematic evaluations. Eur. J. Clin. Invest. -:x-x
  22. Ioannidis, J.P.A. (2020) Infection fatality rate of Covid-19 inferred from seroprevalence data. Bulletin of the World Health Organisation.
  23. Orient, J. et al. (2020) A Guide to Home-Based COVID Treatment.
  24. McCullough, P.A. et al. (2020) Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19). Reviews in cardiovascular medicine 21:517-530
  25. Procter, B.C. et al. (2021) Early Ambulatory Multidrug Therapy Reduces Hospitalization and Death in High-Risk Patients with SARS-CoV-2 (COVID-19). International journal of innovative research in medical science 6:219-221
  26. McCullough, P.A. et al. (2021) Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection. Am. J. Med. 134:16-22
  27. Anonymous, (2020) Real-time database and meta analysis of 588 COVID-19 studies.
  28. Hirschhorn, J.S. (2021) COVID scandal: Feds ignored 2016 law requiring use of real world evidence.
  29. Anonymous, (1998) Emergency Use of an Investigational Drug or Biologic: Guidance for Institutional Review Boards and Clinical Investigators.
  30. Anonymous, (2021) EMA assessment report: Comirnaty.
  31. Anonymous, (2020) FDA briefing document: Pfizer-BioNTech COVID-19 Vaccine.
  32. Giurgea, L.T. and Memoli, M.J. (2020) Navigating the Quagmire: Comparison and Interpretation of COVID-19 Vaccine Phase 1/2 Clinical Trials. Vaccines 8:746
  33. Bhakdi, S. et al. (2021) Urgent Open Letter from Doctors and Scientists to the European Medicines Agency regarding COVID-19 Vaccine Safety Concerns.
  34. Bhakdi, S. (2021) Rebuttal letter to European Medicines Agency from Doctors for Covid Ethics, April 1, 2021.
  35. Ulm, J.W. (2020) Rapid response to: Will covid-19 vaccines save lives? Current trials aren’t designed to tell us.
  36. Reimann, N. (2021) Covid Spiking In Over A Dozen States—Most With High Vaccination Rates.
  37. Meredith, S. (2021) Chile has one of the world’s best vaccination rates. Covid is surging there anyway.
  38. Bhuyan, A. (2021) Covid-19: India sees new spike in cases despite vaccine rollout. BMJ 372:n854
  39. Morrissey, K. (2021) Open letter to Dr. Karina Butler.
  40. Anonymous, (2021) Open Letter from the UK Medical Freedom Alliance: Urgent warning re Covid-19 vaccine-related deaths in the elderly and Care Homes.
  41. Furer, V. et al. (2021) Herpes zoster following BNT162b2 mRNA Covid-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series. Rheumatology -:x-x
  42. Anonymous, (2021) Covid-19 vaccines: ethical, legal and practical considerations.
  43. Tseng, C. et al. (2012) Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus. PLoS One 7:e35421
  44. Bolles, M. et al. (2011) A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge. J. Virol. 85:12201-15
  45. Weingartl, H. et al. (2004) Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets. J. Virol. 78:12672-6
  46. Czub, M. et al. (2005) Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets. Vaccine 23:2273-9
  47. Tinari, S. (2021) The EMA covid-19 data leak, and what it tells us about mRNA instability. BMJ 372:n627
  48. Anonymous, (2021) Interview with Dr. Vanessa Schmidt-Krüger.